Myriad Genetics, Inc.

Myriad Genetics, Inc.verified

MYGN

Price:

$25.29

Market Cap:

$2.29B

Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing the risks for hereditary cancers; BRACAnalysis CDx Germline Companion Diagnostic Test, a DNA sequencing test to help determine the therapy for patients with metastatic breast, ovarian, metastatic pancreatic, or metastatic prostate cancer with deleterious or suspected deleterious germline BRCA variants; and MyChoice CDx Companion Diagnostic Test, a tum...[Read more]

Industry

Medical - Diagnostics & Research

IPO Date

1995-10-06

Stock Exchange

NASDAQ

Ticker

MYGN

The PE Ratio as of May 2024 (TTM) for Myriad Genetics, Inc. (MYGN) is -9.03

According to Myriad Genetics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -9.03. This represents a change of 44.22% compared to the average of -6.26 of the last 4 quarters.

Myriad Genetics, Inc. (MYGN) Historical PE Ratio (quarterly & annually)

How has MYGN PE Ratio performed in the past?

The mean historical PE Ratio of Myriad Genetics, Inc. over the last ten years is 68.93. The current -9.03 PE Ratio has changed -1409.97% with respect to the historical average. Over the past ten years (40 quarters), MYGN's PE Ratio was at its highest in in the December 2018 quarter at 207.40. The PE Ratio was at its lowest in in the September 2018 quarter at -1116.00.

Quarterly (TTM)
Annual

Average

68.93

Median

18.45

Minimum

-78.86

Maximum

439.24

Myriad Genetics, Inc. (MYGN) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Myriad Genetics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 2.12%

Maximum Annual PE Ratio = 439.24

Minimum Annual Increase = -103.64%

Minimum Annual PE Ratio = -78.86

Quarterly (TTM)
Annual
YearPE RatioChange
2022-10.44-86.76%
2021-78.861.09%
2020-6.60-103.64%
2020181.19-58.75%
2019439.242.12%
201819.80-75.55%
201780.96373.57%
201617.09-43.43%
201530.2280.68%
201416.7211.28%

Myriad Genetics, Inc. (MYGN) Average PE Ratio

How has MYGN PE Ratio performed in the past?

The current PE Ratio of Myriad Genetics, Inc. (MYGN) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-31.97

5-year avg

104.91

10-year avg

68.93

Myriad Genetics, Inc. (MYGN) PE Ratio vs. Peers

How is MYGN’s PE Ratio compared to its peers?

Myriad Genetics, Inc.’s PE Ratio is less than Guardant Health, Inc. (-6.70), less than CareDx, Inc (-4.37), less than Invitae Corporation (-0.00), greater than Castle Biosciences, Inc. (-21.63), less than Sotera Health Company (58.02), less than Syneos Health, Inc. (62.97), less than Neogen Corporation (1.87K), less than RadNet, Inc. (187.20), greater than Natera, Inc. (-35.19), less than Medpace Holdings, Inc. (38.82), less than Personalis, Inc. (-0.77), less than Qiagen N.V. (30.08), greater than Olink Holding AB (publ) (-88.39), less than Aclaris Therapeutics, Inc. (-1.09), greater than Exact Sciences Corporation (-38.24), greater than Illumina, Inc. (-13.69), greater than Twist Bioscience Corporation (-14.14),

Build a custom stock screener for Myriad Genetics, Inc. (MYGN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Myriad Genetics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Myriad Genetics, Inc. (MYGN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Myriad Genetics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Myriad Genetics, Inc.'s PE Ratio?

How is the PE Ratio calculated for Myriad Genetics, Inc. (MYGN)?

What is the highest PE Ratio for Myriad Genetics, Inc. (MYGN)?

What is the 3-year average PE Ratio for Myriad Genetics, Inc. (MYGN)?

What is the 5-year average PE Ratio for Myriad Genetics, Inc. (MYGN)?

How does the current PE Ratio for Myriad Genetics, Inc. (MYGN) compare to its historical average?